Abstract
Although endothelial cells are not immunological cells in sensu stricto, they play an important role in controlling inflammation/immune responses. The endothelium is involved in a wide range of pathologies, the most common being vascular diseases and cancer, and they also are central to transplant rejection. Genetic modification of endothelium allows different strategies for inducing tolerance, modulating inflammation, stimulating the immune response or inhibiting the formation of new blood vessels. In this context, the lack of effective and specific pharmacological interventions renders endothelial cells extremely attractive for gene therapy applications. Despite efforts made to genetically modify endothelial cells, the results obtained have suffered from the differences of the endothelium at the different anatomical sites. Several studies are currently being developed to specifically target endothelium using viral and non viral gene delivery approaches. We highlight here some strategies used for genetically manipulating endothelial cells with the aim of inducing tolerance to allograft, or enhancing immunity and/or inhibiting uncontrolled endothelial cell proliferation in tumours.
Keywords: Endothelial cells, gene transfer, gene delivery, inflammation, immune response
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Modulation of the Immune Response by Targeting Endothelial Cells
Volume: 6 Issue: 2
Author(s): Maria Manunta, Peng Hong Tan and Andrew John Timothy George
Affiliation:
Keywords: Endothelial cells, gene transfer, gene delivery, inflammation, immune response
Abstract: Although endothelial cells are not immunological cells in sensu stricto, they play an important role in controlling inflammation/immune responses. The endothelium is involved in a wide range of pathologies, the most common being vascular diseases and cancer, and they also are central to transplant rejection. Genetic modification of endothelium allows different strategies for inducing tolerance, modulating inflammation, stimulating the immune response or inhibiting the formation of new blood vessels. In this context, the lack of effective and specific pharmacological interventions renders endothelial cells extremely attractive for gene therapy applications. Despite efforts made to genetically modify endothelial cells, the results obtained have suffered from the differences of the endothelium at the different anatomical sites. Several studies are currently being developed to specifically target endothelium using viral and non viral gene delivery approaches. We highlight here some strategies used for genetically manipulating endothelial cells with the aim of inducing tolerance to allograft, or enhancing immunity and/or inhibiting uncontrolled endothelial cell proliferation in tumours.
Export Options
About this article
Cite this article as:
Manunta Maria, Hong Tan Peng and John Timothy George Andrew, Modulation of the Immune Response by Targeting Endothelial Cells, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2007; 6 (2) . https://dx.doi.org/10.2174/187152307780598045
DOI https://dx.doi.org/10.2174/187152307780598045 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiovascular Disease Risk Among the Poor and Homeless – What We Know So Far
Current Cardiology Reviews Drug Eluting Stents and Beyond
Current Pharmaceutical Design The Prothrombotic State in Hypertension and the Effects of Antihypertensive Treatment
Current Pharmaceutical Design Current Management of Extracranial Carotid Artery Disease
Reviews on Recent Clinical Trials Drug-Coated Balloons Applications in Interventional Cardiology
Current Pharmaceutical Design Antiplatelet Therapy in Atherothrombotic Cardiovascular Diseases for Primary and Secondary Prevention: A Focus on Old and New Antiplatelet Agents
Current Pharmaceutical Design Editorial: New Insights into a Classical Pathway: Key Roles of the Mevalonate Cascade in Different Diseases (Part II)
Current Molecular Pharmacology Tauopathies – Focus on Changes at the Neurovascular Unit
Current Alzheimer Research Hemolysis-Associated Pulmonary Hypertension in Sickle Cell Disease: Global Disruption of the Arginine-Nitric Oxide Pathway
Current Hypertension Reviews Recognition and Impact of Host-derived Molecules on Bacterial Cell-tocell Signalling Pathways
Medicinal Chemistry Evolution of Exenatide as a Diabetes Therapeutic
Current Diabetes Reviews Nutritional Antioxidants and Their Applications in Cardiometabolic Diseases
Infectious Disorders - Drug Targets Atherosclerotic Process in Seroreverter Children and Adolescents Exposed to Fetal Antiretroviral Therapy
Current HIV Research The Mode of Action of the Antidiabetic Drug Glimepiride-Beyond Insulin Secretion
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Millennium Nutrient N,N-Dimethylglycine (DMG) and its Effectiveness in Autism Spectrum Disorders
Current Medicinal Chemistry Current Updates on Therapeutic Advances in the Management of Cardiovascular Diseases
Current Pharmaceutical Design L-Arginine Signalling Potential in the Brain: The Peripheral Gets Central
Recent Patents on CNS Drug Discovery (Discontinued) Meet Our Editor:
Current Hypertension Reviews Soy Isoflavones and Cardiovascular Disease Epidemiological, Clinical and -Omics Perspectives
Current Pharmaceutical Biotechnology Metabolic Programming Nowadays (or Perhaps Now and then?)
Current Nutrition & Food Science